Treatment-related Adverse Events, Including Fatal Toxicities, in Patients With Extensive-stage Small-cell Lung Cancer Receiving Adjuvant Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitors: A Meta-analysis and Trial Sequential Analysis of Randomized Controlled Trials
-
Published:2024-10
Issue:10
Volume:36
Page:e408-e419
-
ISSN:0936-6555
-
Container-title:Clinical Oncology
-
language:en
-
Short-container-title:Clinical Oncology
Author:
Moraes F.C.A. deORCID,
Lôbo A. de O.M.ORCID,
Sano V.K.T.ORCID,
Kelly F.A.ORCID,
Burbano R.M.R.ORCID